Skip to main content

Larimar Therapeutics, Inc.

LRMR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001374690

In the last 90 days, Larimar Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 163 institutions reported holding it in 13F filings for Q2 2026, worth $291.4M in total; no superinvestor holds it.

13F holders, Q1 2022

Institutional positions in Larimar Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
45
−4 vs. Q4 2021
Shares held
15.3M
+690.4K (+4.7%) vs. Q4 2021
Total value
$61.8M
−$95.4M (−60.7%) vs. Q4 2021
New holders
2
14 more added
Sold out
6
11 more reduced

Compare with Q4 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting LRMR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2022: 45 institutions
Q1 2021: 57 institutionsQ2 2021: 45 institutionsQ3 2021: 54 institutionsQ4 2021: 49 institutionsQ1 2022: 45 institutionsQ2 2022: 40 institutionsQ3 2022: 59 institutionsQ4 2022: 48 institutionsQ1 2023: 69 institutionsQ2 2023: 65 institutionsQ3 2023: 65 institutionsQ4 2023: 69 institutionsQ1 2024: 104 institutionsQ2 2024: 107 institutionsQ3 2024: 123 institutionsQ4 2024: 116 institutionsQ1 2025: 103 institutionsQ2 2025: 116 institutionsQ3 2025: 136 institutionsQ4 2025: 136 institutionsQ1 2026: 162 institutionsQ2 2026: 163 institutions
Value heldQ1 2022: $61.8M
Q1 2021: $206.1MQ2 2021: $142.8MQ3 2021: $167.5MQ4 2021: $157.2MQ1 2022: $61.8MQ2 2022: $28.2MQ3 2022: $123.9MQ4 2022: $160.1MQ1 2023: $174.2MQ2 2023: $120.2MQ3 2023: $153.0MQ4 2023: $179.6MQ1 2024: $482.8MQ2 2024: $473.5MQ3 2024: $421.3MQ4 2024: $245.5MQ1 2025: $131.9MQ2 2025: $180.1MQ3 2025: $274.8MQ4 2025: $277.0MQ1 2026: $394.8MQ2 2026: $291.4M
Institutions holding LRMR and their total value by quarter
QuarterHoldersValue
Q2 2026163$291.4M
Q1 2026162$394.8M
Q4 2025136$277.0M
Q3 2025136$274.8M
Q2 2025116$180.1M
Q1 2025103$131.9M
Q4 2024116$245.5M
Q3 2024123$421.3M
Q2 2024107$473.5M
Q1 2024104$482.8M
Q4 202369$179.6M
Q3 202365$153.0M
Q2 202365$120.2M
Q1 202369$174.2M
Q4 202248$160.1M
Q3 202259$123.9M
Q2 202240$28.2M
Q1 202245$61.8M
Q4 202149$157.2M
Q3 202154$167.5M
Q2 202145$142.8M
Q1 202157$206.1M

Institutions, Q1 2022

Shares, value and share of portfolio for each institution holding Larimar Therapeutics, Inc.; share changes are against Q4 2021.

Institutions holding LRMR in Q1 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Deerfield Management Company, L.P. (Series C)5,830,249$23.6M0.53%00.0%Unchanged
CHI Advisors LLC1,515,148$6.14M2.61%00.0%Unchanged
Ra Capital Management, L.P.1,281,860$5.19M0.11%−52,750−4.0%Reduced
Janus Henderson Group PLC1,045,245$4.22M0.00%+310,133+42.2%Added
Opaleye Management Inc.943,702$3.82M1.19%+60,100+6.8%Added
Mangrove Partners867,812$3.52M0.28%+627,859+261.7%Added
Morgan Stanley529,984$2.15M0.00%+518,189+4,393.3%Added
Vanguard Group Inc511,082$2.07M0.00%−14,961−2.8%Reduced
Verition Fund Management LLC424,599$1.72M0.03%+188,764+80.0%Added
Atlas Venture Advisors, Inc.292,184$1.18M0.25%00.0%Unchanged
683 Capital Management, LLC250,000$1.01M0.06%−6,620−2.6%Reduced
BlackRock Inc.245,856$996.0K0.00%+959+0.4%Added
Driehaus Capital Management LLC210,500$853.0K0.01%00.0%Unchanged
Adage Capital Partners GP, L.L.C.176,680$716.0K0.00%00.0%Unchanged
Renaissance Technologies LLC172,742$700.0K0.00%−20,032−10.4%Reduced
Fi3 FINANCIAL ADVISORS, LLC121,818$493.0K0.38%00.0%Unchanged
Bank of America Corp116,223$471.0K0.00%+43,713+60.3%Added
Geode Capital Management, LLC113,890$461.0K0.00%00.0%Unchanged
Ghost Tree Capital, LLC100,000$405.0K0.20%−125,000−55.6%Reduced
Bridgeway Capital Management, LLC62,800$254.0K0.00%00.0%Unchanged
Susquehanna International Group, LLP55,366$224.0K0.00%−43,974−44.3%Reduced
Difesa Capital Management, LP52,050$211.0K0.13%−400−0.8%Reduced
Ikarian Capital, LLC51,606$209.0K0.06%+4,413+9.4%Added
DAFNA Capital Management LLC49,996$202.0K0.05%−20,181−28.8%Reduced
State Street Corp41,450$168.0K0.00%+2,417+6.2%Added
Golden State Equity Partners30,415$123.0K0.06%+5,400+21.6%Added
Two Sigma Investments, LP28,412$115.0K0.00%+9,701+51.8%Added
Dimensional Fund Advisors LP28,138$114.0K0.00%00.0%Unchanged
Royce & Associates LP28,064$114.0K0.00%00.0%Unchanged
Northern Trust Corp21,330$86.0K0.00%00.0%Unchanged
Bank of New York Mellon Corp18,973$77.0K0.00%00.0%Unchanged
Two Sigma Advisers, LP13,998$57.0K0.00%−14,200−50.4%Reduced
Citadel Advisors LLC12,897$52.0K0.00%+12,897New
Solstein Capital, LLC4,477$18.0K0.01%00.0%Unchanged
JPMorgan Chase & Co2,101$9.00K0.00%+523+33.1%Added
UBS Group AG1,733$7.00K0.00%+612+54.6%Added
US Bancorp1,175$5.00K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)1,215$5.00K0.00%+89+7.9%Added
Cutler Group LP1,200$4.00K0.00%00.0%Unchanged
Citigroup Inc386$2.00K0.00%−158−29.0%Reduced
Global Retirement Partners, LLC225$1.00K0.00%+225New
Simplex Trading, LLC46$00.00%−836−94.8%Reduced
Disciplined Investments, LLC116$00.00%00.0%Unchanged
Daiwa Securities Group Inc.29$00.00%00.0%Unchanged
Advisor Group Holdings, Inc.29$00.00%00.0%Unchanged
Vivo Capital, LLC0$00.00%−399,830−100.0%Sold out
Point72 Asset Management, L.P.0$00.00%−196,896−100.0%Sold out
Fred Alger Management, LLC0$00.00%−175,870−100.0%Sold out
Marshall Wace, LLP0$00.00%−11,392−100.0%Sold out
Northeast Financial Consultants Inc0$00.00%−10,105−100.0%Sold out
Zurcher Kantonalbank (Zurich Cantonalbank)0$00.00%−2,395−100.0%Sold out